0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global NGS Based Diagnostics Market Insights and Forecast to 2028
Published Date: February 2022
|
Report Code: QYRE-Auto-9T1976
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global NGS Based Diagnostics Market Insights and Forecast to 2028
BUY CHAPTERS

Global NGS Based Diagnostics Market Insights and Forecast to 2028

Code: QYRE-Auto-9T1976
Report
February 2022
107 Pages
QYResearch
Region: Global, North America, Europe, Japan, Central & South America
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

NGS Based Diagnostics Market 

Next generation sequencing (NGS) based diagnostics are the medical devices used for diagnosis of various conditions using advanced generation sequencing platforms.

The global NGS Based Diagnostics market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

North America is currently leading the market due to the research and innovations and presence of maximum numbers of players. Europe is following America. Rising caseload of cancer, incidence of drug-resistant infectious diseases in Asian and African countries have created a huge demand of such technologies. Hence, market will grow at a fast pace in these regions.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global NGS Based Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global NGS Based Diagnostics market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global NGS Based Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global NGS Based Diagnostics market.

NGS Based Diagnostics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global NGS Based Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

By Type

  • DNA Sequencing
  • RNA Sequencing
  • Whole Genome Sequencing
  • Whole Exome Sequencing
  • Other

By Application

  • Hospitals
  • Clinics
  • Academics/Research Institutions

Key Type

  • Janssen
  • Roche
  • Qiagen
  • ThermoFisher Scientific
  • Oxford Gene Technology
  • Illumina
  • Pacific Biosciences
  • Paradigm Diagnostics
  • Innogene Kalbiotech
  • Admera Health
  • AITbiotech
  • Centogene
  • Phalanx Biotech Group
  • iGenomX

By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NGS Based Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 DNA Sequencing
1.2.3 RNA Sequencing
1.2.4 Whole Genome Sequencing
1.2.5 Whole Exome Sequencing
1.2.6 Other
1.3 Market by Application
1.3.1 Global NGS Based Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Academics/Research Institutions
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global NGS Based Diagnostics Market Perspective (2017-2028)
2.2 NGS Based Diagnostics Growth Trends by Region
2.2.1 NGS Based Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 NGS Based Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 NGS Based Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 NGS Based Diagnostics Market Dynamics
2.3.1 NGS Based Diagnostics Industry Trends
2.3.2 NGS Based Diagnostics Market Drivers
2.3.3 NGS Based Diagnostics Market Challenges
2.3.4 NGS Based Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top NGS Based Diagnostics Players by Revenue
3.1.1 Global Top NGS Based Diagnostics Players by Revenue (2017-2022)
3.1.2 Global NGS Based Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global NGS Based Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by NGS Based Diagnostics Revenue
3.4 Global NGS Based Diagnostics Market Concentration Ratio
3.4.1 Global NGS Based Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NGS Based Diagnostics Revenue in 2021
3.5 NGS Based Diagnostics Key Players Head office and Area Served
3.6 Key Players NGS Based Diagnostics Product Solution and Service
3.7 Date of Enter into NGS Based Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 NGS Based Diagnostics Breakdown Data by Type
4.1 Global NGS Based Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global NGS Based Diagnostics Forecasted Market Size by Type (2023-2028)
5 NGS Based Diagnostics Breakdown Data by Application
5.1 Global NGS Based Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global NGS Based Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America NGS Based Diagnostics Market Size (2017-2028)
6.2 North America NGS Based Diagnostics Market Size by Type
6.2.1 North America NGS Based Diagnostics Market Size by Type (2017-2022)
6.2.2 North America NGS Based Diagnostics Market Size by Type (2023-2028)
6.2.3 North America NGS Based Diagnostics Market Share by Type (2017-2028)
6.3 North America NGS Based Diagnostics Market Size by Application
6.3.1 North America NGS Based Diagnostics Market Size by Application (2017-2022)
6.3.2 North America NGS Based Diagnostics Market Size by Application (2023-2028)
6.3.3 North America NGS Based Diagnostics Market Share by Application (2017-2028)
6.4 North America NGS Based Diagnostics Market Size by Country
6.4.1 North America NGS Based Diagnostics Market Size by Country (2017-2022)
6.4.2 North America NGS Based Diagnostics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe NGS Based Diagnostics Market Size (2017-2028)
7.2 Europe NGS Based Diagnostics Market Size by Type
7.2.1 Europe NGS Based Diagnostics Market Size by Type (2017-2022)
7.2.2 Europe NGS Based Diagnostics Market Size by Type (2023-2028)
7.2.3 Europe NGS Based Diagnostics Market Share by Type (2017-2028)
7.3 Europe NGS Based Diagnostics Market Size by Application
7.3.1 Europe NGS Based Diagnostics Market Size by Application (2017-2022)
7.3.2 Europe NGS Based Diagnostics Market Size by Application (2023-2028)
7.3.3 Europe NGS Based Diagnostics Market Share by Application (2017-2028)
7.4 Europe NGS Based Diagnostics Market Size by Country
7.4.1 Europe NGS Based Diagnostics Market Size by Country (2017-2022)
7.4.2 Europe NGS Based Diagnostics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific NGS Based Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific NGS Based Diagnostics Market Size by Type
8.2.1 Asia-Pacific NGS Based Diagnostics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific NGS Based Diagnostics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific NGS Based Diagnostics Market Share by Type (2017-2028)
8.3 Asia-Pacific NGS Based Diagnostics Market Size by Application
8.3.1 Asia-Pacific NGS Based Diagnostics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific NGS Based Diagnostics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific NGS Based Diagnostics Market Share by Application (2017-2028)
8.4 Asia-Pacific NGS Based Diagnostics Market Size by Region
8.4.1 Asia-Pacific NGS Based Diagnostics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific NGS Based Diagnostics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America NGS Based Diagnostics Market Size (2017-2028)
9.2 Latin America NGS Based Diagnostics Market Size by Type
9.2.1 Latin America NGS Based Diagnostics Market Size by Type (2017-2022)
9.2.2 Latin America NGS Based Diagnostics Market Size by Type (2023-2028)
9.2.3 Latin America NGS Based Diagnostics Market Share by Type (2017-2028)
9.3 Latin America NGS Based Diagnostics Market Size by Application
9.3.1 Latin America NGS Based Diagnostics Market Size by Application (2017-2022)
9.3.2 Latin America NGS Based Diagnostics Market Size by Application (2023-2028)
9.3.3 Latin America NGS Based Diagnostics Market Share by Application (2017-2028)
9.4 Latin America NGS Based Diagnostics Market Size by Country
9.4.1 Latin America NGS Based Diagnostics Market Size by Country (2017-2022)
9.4.2 Latin America NGS Based Diagnostics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa NGS Based Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa NGS Based Diagnostics Market Size by Type
10.2.1 Middle East & Africa NGS Based Diagnostics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa NGS Based Diagnostics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa NGS Based Diagnostics Market Share by Type (2017-2028)
10.3 Middle East & Africa NGS Based Diagnostics Market Size by Application
10.3.1 Middle East & Africa NGS Based Diagnostics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa NGS Based Diagnostics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa NGS Based Diagnostics Market Share by Application (2017-2028)
10.4 Middle East & Africa NGS Based Diagnostics Market Size by Country
10.4.1 Middle East & Africa NGS Based Diagnostics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa NGS Based Diagnostics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Janssen
11.1.1 Janssen Company Details
11.1.2 Janssen Business Overview
11.1.3 Janssen NGS Based Diagnostics Introduction
11.1.4 Janssen Revenue in NGS Based Diagnostics Business (2017-2022)
11.1.5 Janssen Recent Developments
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche NGS Based Diagnostics Introduction
11.2.4 Roche Revenue in NGS Based Diagnostics Business (2017-2022)
11.2.5 Roche Recent Developments
11.3 Qiagen
11.3.1 Qiagen Company Details
11.3.2 Qiagen Business Overview
11.3.3 Qiagen NGS Based Diagnostics Introduction
11.3.4 Qiagen Revenue in NGS Based Diagnostics Business (2017-2022)
11.3.5 Qiagen Recent Developments
11.4 ThermoFisher Scientific
11.4.1 ThermoFisher Scientific Company Details
11.4.2 ThermoFisher Scientific Business Overview
11.4.3 ThermoFisher Scientific NGS Based Diagnostics Introduction
11.4.4 ThermoFisher Scientific Revenue in NGS Based Diagnostics Business (2017-2022)
11.4.5 ThermoFisher Scientific Recent Developments
11.5 Oxford Gene Technology
11.5.1 Oxford Gene Technology Company Details
11.5.2 Oxford Gene Technology Business Overview
11.5.3 Oxford Gene Technology NGS Based Diagnostics Introduction
11.5.4 Oxford Gene Technology Revenue in NGS Based Diagnostics Business (2017-2022)
11.5.5 Oxford Gene Technology Recent Developments
11.6 Illumina
11.6.1 Illumina Company Details
11.6.2 Illumina Business Overview
11.6.3 Illumina NGS Based Diagnostics Introduction
11.6.4 Illumina Revenue in NGS Based Diagnostics Business (2017-2022)
11.6.5 Illumina Recent Developments
11.7 Pacific Biosciences
11.7.1 Pacific Biosciences Company Details
11.7.2 Pacific Biosciences Business Overview
11.7.3 Pacific Biosciences NGS Based Diagnostics Introduction
11.7.4 Pacific Biosciences Revenue in NGS Based Diagnostics Business (2017-2022)
11.7.5 Pacific Biosciences Recent Developments
11.8 Paradigm Diagnostics
11.8.1 Paradigm Diagnostics Company Details
11.8.2 Paradigm Diagnostics Business Overview
11.8.3 Paradigm Diagnostics NGS Based Diagnostics Introduction
11.8.4 Paradigm Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022)
11.8.5 Paradigm Diagnostics Recent Developments
11.9 Innogene Kalbiotech
11.9.1 Innogene Kalbiotech Company Details
11.9.2 Innogene Kalbiotech Business Overview
11.9.3 Innogene Kalbiotech NGS Based Diagnostics Introduction
11.9.4 Innogene Kalbiotech Revenue in NGS Based Diagnostics Business (2017-2022)
11.9.5 Innogene Kalbiotech Recent Developments
11.10 Admera Health
11.10.1 Admera Health Company Details
11.10.2 Admera Health Business Overview
11.10.3 Admera Health NGS Based Diagnostics Introduction
11.10.4 Admera Health Revenue in NGS Based Diagnostics Business (2017-2022)
11.10.5 Admera Health Recent Developments
11.11 AITbiotech
11.11.1 AITbiotech Company Details
11.11.2 AITbiotech Business Overview
11.11.3 AITbiotech NGS Based Diagnostics Introduction
11.11.4 AITbiotech Revenue in NGS Based Diagnostics Business (2017-2022)
11.11.5 AITbiotech Recent Developments
11.12 Centogene
11.12.1 Centogene Company Details
11.12.2 Centogene Business Overview
11.12.3 Centogene NGS Based Diagnostics Introduction
11.12.4 Centogene Revenue in NGS Based Diagnostics Business (2017-2022)
11.12.5 Centogene Recent Developments
11.13 Phalanx Biotech Group
11.13.1 Phalanx Biotech Group Company Details
11.13.2 Phalanx Biotech Group Business Overview
11.13.3 Phalanx Biotech Group NGS Based Diagnostics Introduction
11.13.4 Phalanx Biotech Group Revenue in NGS Based Diagnostics Business (2017-2022)
11.13.5 Phalanx Biotech Group Recent Developments
11.14 iGenomX
11.14.1 iGenomX Company Details
11.14.2 iGenomX Business Overview
11.14.3 iGenomX NGS Based Diagnostics Introduction
11.14.4 iGenomX Revenue in NGS Based Diagnostics Business (2017-2022)
11.14.5 iGenomX Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Global NGS Based Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of DNA Sequencing
    Table 3. Key Players of RNA Sequencing
    Table 4. Key Players of Whole Genome Sequencing
    Table 5. Key Players of Whole Exome Sequencing
    Table 6. Key Players of Other
    Table 7. Global NGS Based Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 8. Global NGS Based Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global NGS Based Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global NGS Based Diagnostics Market Share by Region (2017-2022)
    Table 11. Global NGS Based Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global NGS Based Diagnostics Market Share by Region (2023-2028)
    Table 13. NGS Based Diagnostics Market Trends
    Table 14. NGS Based Diagnostics Market Drivers
    Table 15. NGS Based Diagnostics Market Challenges
    Table 16. NGS Based Diagnostics Market Restraints
    Table 17. Global NGS Based Diagnostics Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global NGS Based Diagnostics Revenue Share by Players (2017-2022)
    Table 19. Global Top NGS Based Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS Based Diagnostics as of 2021)
    Table 20. Ranking of Global Top NGS Based Diagnostics Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by NGS Based Diagnostics Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players NGS Based Diagnostics Product Solution and Service
    Table 24. Date of Enter into NGS Based Diagnostics Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global NGS Based Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global NGS Based Diagnostics Revenue Market Share by Type (2017-2022)
    Table 28. Global NGS Based Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global NGS Based Diagnostics Revenue Market Share by Type (2023-2028)
    Table 30. Global NGS Based Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global NGS Based Diagnostics Revenue Share by Application (2017-2022)
    Table 32. Global NGS Based Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global NGS Based Diagnostics Revenue Share by Application (2023-2028)
    Table 34. North America NGS Based Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 35. North America NGS Based Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 36. North America NGS Based Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 37. North America NGS Based Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 38. North America NGS Based Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 39. North America NGS Based Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Europe NGS Based Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 41. Europe NGS Based Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 42. Europe NGS Based Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 43. Europe NGS Based Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 44. Europe NGS Based Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Europe NGS Based Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Asia Pacific NGS Based Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 47. Asia Pacific NGS Based Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 48. Asia Pacific NGS Based Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 49. Asia Pacific NGS Based Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 50. Asia Pacific NGS Based Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 51. Asia Pacific NGS Based Diagnostics Market Size by Region (2023-2028) & (US$ Million)
    Table 52. Latin America NGS Based Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 53. Latin America NGS Based Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 54. Latin America NGS Based Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 55. Latin America NGS Based Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 56. Latin America NGS Based Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 57. Latin America NGS Based Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa NGS Based Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa NGS Based Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa NGS Based Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa NGS Based Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa NGS Based Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa NGS Based Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 64. Janssen Company Details
    Table 65. Janssen Business Overview
    Table 66. Janssen NGS Based Diagnostics Product
    Table 67. Janssen Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 68. Janssen Recent Developments
    Table 69. Roche Company Details
    Table 70. Roche Business Overview
    Table 71. Roche NGS Based Diagnostics Product
    Table 72. Roche Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 73. Roche Recent Developments
    Table 74. Qiagen Company Details
    Table 75. Qiagen Business Overview
    Table 76. Qiagen NGS Based Diagnostics Product
    Table 77. Qiagen Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 78. Qiagen Recent Developments
    Table 79. ThermoFisher Scientific Company Details
    Table 80. ThermoFisher Scientific Business Overview
    Table 81. ThermoFisher Scientific NGS Based Diagnostics Product
    Table 82. ThermoFisher Scientific Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 83. ThermoFisher Scientific Recent Developments
    Table 84. Oxford Gene Technology Company Details
    Table 85. Oxford Gene Technology Business Overview
    Table 86. Oxford Gene Technology NGS Based Diagnostics Product
    Table 87. Oxford Gene Technology Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 88. Oxford Gene Technology Recent Developments
    Table 89. Illumina Company Details
    Table 90. Illumina Business Overview
    Table 91. Illumina NGS Based Diagnostics Product
    Table 92. Illumina Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 93. Illumina Recent Developments
    Table 94. Pacific Biosciences Company Details
    Table 95. Pacific Biosciences Business Overview
    Table 96. Pacific Biosciences NGS Based Diagnostics Product
    Table 97. Pacific Biosciences Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 98. Pacific Biosciences Recent Developments
    Table 99. Paradigm Diagnostics Company Details
    Table 100. Paradigm Diagnostics Business Overview
    Table 101. Paradigm Diagnostics NGS Based Diagnostics Product
    Table 102. Paradigm Diagnostics Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 103. Paradigm Diagnostics Recent Developments
    Table 104. Innogene Kalbiotech Company Details
    Table 105. Innogene Kalbiotech Business Overview
    Table 106. Innogene Kalbiotech NGS Based Diagnostics Product
    Table 107. Innogene Kalbiotech Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 108. Innogene Kalbiotech Recent Developments
    Table 109. Admera Health Company Details
    Table 110. Admera Health Business Overview
    Table 111. Admera Health NGS Based Diagnostics Product
    Table 112. Admera Health Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 113. Admera Health Recent Developments
    Table 114. AITbiotech Company Details
    Table 115. AITbiotech Business Overview
    Table 116. AITbiotech NGS Based Diagnostics Product
    Table 117. AITbiotech Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 118. AITbiotech Recent Developments
    Table 119. Centogene Company Details
    Table 120. Centogene Business Overview
    Table 121. Centogene NGS Based Diagnostics Product
    Table 122. Centogene Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 123. Centogene Recent Developments
    Table 124. Phalanx Biotech Group Company Details
    Table 125. Phalanx Biotech Group Business Overview
    Table 126. Phalanx Biotech Group NGS Based Diagnostics Product
    Table 127. Phalanx Biotech Group Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 128. Phalanx Biotech Group Recent Developments
    Table 129. iGenomX Company Details
    Table 130. iGenomX Business Overview
    Table 131. iGenomX NGS Based Diagnostics Product
    Table 132. iGenomX Revenue in NGS Based Diagnostics Business (2017-2022) & (US$ Million)
    Table 133. iGenomX Recent Developments
    Table 134. Research Programs/Design for This Report
    Table 135. Key Data Information from Secondary Sources
    Table 136. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global NGS Based Diagnostics Market Share by Type: 2021 VS 2028
    Figure 2. DNA Sequencing Features
    Figure 3. RNA Sequencing Features
    Figure 4. Whole Genome Sequencing Features
    Figure 5. Whole Exome Sequencing Features
    Figure 6. Other Features
    Figure 7. Global NGS Based Diagnostics Market Share by Application: 2021 VS 2028
    Figure 8. Hospitals Case Studies
    Figure 9. Clinics Case Studies
    Figure 10. Academics/Research Institutions Case Studies
    Figure 11. NGS Based Diagnostics Report Years Considered
    Figure 12. Global NGS Based Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global NGS Based Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global NGS Based Diagnostics Market Share by Region: 2021 VS 2028
    Figure 15. Global NGS Based Diagnostics Market Share by Players in 2021
    Figure 16. Global Top NGS Based Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS Based Diagnostics as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by NGS Based Diagnostics Revenue in 2021
    Figure 18. North America NGS Based Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 19. North America NGS Based Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 20. North America NGS Based Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 21. North America NGS Based Diagnostics Market Size Share by Country (2017-2028)
    Figure 22. United States NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe NGS Based Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 25. Europe NGS Based Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 26. Europe NGS Based Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 27. Europe NGS Based Diagnostics Market Size Share by Country (2017-2028)
    Figure 28. Germany NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. France NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. U.K. NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Italy NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Russia NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Nordic Countries NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific NGS Based Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 35. Asia Pacific NGS Based Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 36. Asia Pacific NGS Based Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 37. Asia Pacific NGS Based Diagnostics Market Size Share by Region (2017-2028)
    Figure 38. China NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Japan NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. South Korea NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Southeast Asia NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. India NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Australia NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 44. Latin America NGS Based Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 45. Latin America NGS Based Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 46. Latin America NGS Based Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 47. Latin America NGS Based Diagnostics Market Size Share by Country (2017-2028)
    Figure 48. Mexico NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Brazil NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa NGS Based Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 51. Middle East and Africa NGS Based Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 52. Middle East and Africa NGS Based Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 53. Middle East and Africa NGS Based Diagnostics Market Size Share by Country (2017-2028)
    Figure 54. Turkey NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. UAE NGS Based Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Janssen Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 58. Roche Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 59. Qiagen Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 60. ThermoFisher Scientific Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 61. Oxford Gene Technology Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 62. Illumina Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 63. Pacific Biosciences Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 64. Paradigm Diagnostics Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 65. Innogene Kalbiotech Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 66. Admera Health Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 67. AITbiotech Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 68. Centogene Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 69. Phalanx Biotech Group Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 70. iGenomX Revenue Growth Rate in NGS Based Diagnostics Business (2017-2022)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Accenture
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Risperidone Market Insights and Forecast to 2028
Global and United States Risperidone Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-34S6889
Mon Nov 07 00:00:00 UTC 2022

Add to Cart

Global Erythropoietin ELISA Test Kit Market Research Report 2022
Global and United States Erythropoietin ELISA Test Kit Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-32I12133
Mon Nov 07 00:00:00 UTC 2022

Add to Cart

Global Synthetic Bioinks Market Research Report 2022
Global and United States Synthetic Bioinks Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-15I12294
Mon Nov 07 00:00:00 UTC 2022

Add to Cart

Global Fluorinated Pharmaceutical Intermediates Market Research Report 2022
Global Fluorinated Pharmaceutical Intermediates Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-18A12300
Thu Nov 03 00:00:00 UTC 2022

Add to Cart